Apr 24, 2025 19:27
PEN - Penumbra, Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
253.34 -0.78 (-0.31%) | --- | --- | --- | --- | -0.78 (-0.31%) | --- | --- |
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- 1.17
- Diluted EPS:
- 1.15
- Basic P/E:
- 215.8632
- Diluted P/E:
- 219.6174
- RSI(14) 1m:
- 58.72
- VWAP:
- 252.54
- RVol:
Events
Period | Kind | Movement | Occurred At |
---|
Related News
Nov 01, 2024 12:00
Oct 14, 2024 22:20
Sep 18, 2024 22:29
Jul 20, 2024 00:10
Jul 04, 2024 06:52
Jun 13, 2024 13:45
Jun 06, 2024 15:31
May 28, 2024 13:45
May 09, 2024 15:40